A widely used coupling agent: Diphenylphosphoryl azide
Diphenylphosphoryl azide is a well-known azide reagent used in peptide couplings, Curtius rearrangements, and Mitsunobu inversions
Dec 1，2023 Chemical Reagents
What does Diphenyl ether do?
Diphenyl ethers are used as carriers for commonly used dyes, as flavouring agents in food additives, as chemical intermediates in the heat transfer medium Dowtherm A and in surfactants and lubricants,
Dec 1，2023 API
Ankaflavin: bioactivities, biosynthesis and applications
Ankaflavin, derived from Monascus, has diverse bioactivities and therapeutic potential, making it valuable for addressing various health conditions.
Dec 1，2023 API
Chebulic Acid: activities, mechanism of action and applications
Chebulic acid possesses diverse pharmacological activities and potential therapeutic applications.
Dec 1，2023 API
Butylchlorodihydroxytin: properties, applications and safety
Butylchlorodihydroxytin has valuable applications but requires adherence to safety guidelines due to potential hazards.
Dec 1，2023 API
Ingenol: pharmacokinetic, mechanism of action and clinical applications
Ingenol, derived from Euphorbia peplus, shows promise in dermatology for its minimal systemic absorption and diverse therapeutic effects.
Dec 1，2023 API
Hydroxychloroquine: mechanisms of action, pharmacokinetics and safety
Hydroxychloroquine has diverse mechanisms of action, pharmacokinetics, and potential adverse effects in treating autoimmune diseases.
Dec 1，2023 API
5-Methyltetrahydrofolic acid: pharmacokinetics and physiological actions
5-Methyltetrahydrofolic acid is a crucial form of folate involved in absorption, distribution, metabolism, and excretion, regulating homocysteine levels.
Dec 1，2023 API
Zirconium n-butoxide: versatile applications and safety
Zirconium n-butoxide enables the synthesis of versatile nanoparticles, composite sols, and unique thio/oxothio clusters, but requires strict safety precautions.
Dec 1，2023 API
ABT-888: pharmacokinetic, mechanism of action and safety
ABT-888, a potent PARP inhibitor with favorable pharmacokinetics, shows promise in cancer therapy.
Dec 1，2023 API